Music Therapy for Severe Dementia
(AMUSED Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if music therapy, known as AMUSED, can improve engagement and reduce behavioral issues in older adults with severe dementia living in care facilities. Researchers seek to establish the feasibility of a larger study and identify the best methods to measure changes in behavior and speech. Participants will either join group music therapy sessions, which include activities like live music and singing, or participate in a reading group. The trial seeks residents in care facilities who have severe dementia and do not currently receive music therapy. As an unphased study, this trial provides a unique opportunity to explore innovative therapies that could enhance quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It is best to consult with the trial coordinators or your healthcare provider for guidance.
What prior data suggests that this music therapy treatment is safe for older adults with severe dementia?
Research has shown that music therapy is generally safe and well-tolerated for people with dementia. Past studies have found that music therapy significantly lowers anxiety, depression, and lack of interest in patients. One study showed that music therapy helped reduce disruptive behavior over six weeks. These results suggest that music therapy, such as AMUSED, is unlikely to cause harm and is probably safe for participants.
Although detailed safety information specifically for AMUSED is not available, music therapy in similar situations has been linked to positive results and is considered low risk. This makes it a promising option for those interested in joining this study.12345Why are researchers excited about this trial?
Researchers are excited about music therapy for severe dementia because it offers a non-drug approach that focuses on stimulating memory and emotions through music, potentially enhancing the quality of life for patients. Unlike standard dementia treatments that often involve medications targeting neurotransmitters, music therapy provides a personalized, interactive experience led by a trained music therapist. This method could offer a meaningful and enjoyable way to engage patients, promoting cognitive and emotional benefits without the side effects associated with pharmaceuticals.
What evidence suggests that music therapy might be an effective treatment for severe dementia?
This trial will compare the effects of music therapy with reading aloud for individuals with severe dementia. Studies have shown that music therapy can improve mood and reduce restlessness in people with severe dementia. Research indicates that music therapy may also help people find words and speak more easily. Additionally, music therapy has been linked to reduced anxiety, depression, and apathy in dementia patients. Evidence suggests that music therapy can enhance thinking skills, such as memory and decision-making. Overall, these findings suggest that music therapy, like AMUSED, might effectively increase engagement and reduce behavioral symptoms in severe dementia.12367
Who Is on the Research Team?
Alaine E Reschke-Hernandez, PhD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This trial is for older adults with severe dementia living in care facilities. They should be able to attend small group sessions and participate in activities. There are no specific inclusion or exclusion criteria provided, but typically participants must meet certain health conditions and not have factors that would prevent them from fully participating.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline measures are taken before the intervention begins
Treatment
Participants receive either music therapy or reading sessions twice a week for 12 weeks
Follow-up
Participants are monitored for behavioral symptoms, cognition, and speech after treatment
What Are the Treatments Tested in This Trial?
Interventions
- AMUSED
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alaine E Hernandez, PhD
Lead Sponsor
National Institute on Aging (NIA)
Collaborator